NorthWest Biotherapeutics Inc (NWBO)

[MI Dendream]

Agree Biosect, I was adding to your point not disagreeing.

You present Encore data in product theaters, not data release.

But….this company is unorthodox. Regardless, I agree with you that the paper (or possibly a late breaker) comes first. I have stopped waiting for late breaker release, but a surprise there does fit the picture and plan. What can be done is you present the 15 min platform late breaker, at the end you invite them to the Product Theater for further details.

Or, you publish the data, then Encore it in the product theater breaking no embargo policies.